Skip to main content
OpenTrials

Clinical trial condition

Hematologic Malignancies

Explore clinical trials studying Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

134 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Malignancies trial results

Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT03486873

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • Arizona Cancer Center at UMC North ( Site 0018) Tucson, Arizona, United States
  • Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054) Bakersfield, California, United States
  • California Cancer Associates for Research & Excellence ( Site 0016) Fresno, California, United States
  • Providence Medical Foundation ( Site 0087) Fullerton, California, United States
View all 780 locations
View Trial Details
Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
Locations
  • Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
  • University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
  • Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
View all 121 locations
View Trial Details
Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

NCT04588922

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 26 locations
View Trial Details
Recruiting

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

NCT06823167

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • City Of Hope Duarte, California, United States
  • University of California Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University Medical Center New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Recruiting

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

NCT07359859

Conditions
Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

NCT01351545

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Anemia, +43 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Mayo Clinic Arizona (adults) Phoenix, Arizona, United States
View all 142 locations
View Trial Details
Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • The University of Nebraska Medical Center Omaha, Nebraska, United States
View all 22 locations
View Trial Details

Related conditions